
Comparing NAD+ Presentations Analytically, Not Clinically
A vial, liquid spray and dissolving strip can contain different analytical matrices even when NAD+ appears in all three names. Recovery from each matrix must be demonstrated rather than assumed equivalent.

Redox Measurements Can Be Changed by Sample Handling
A glutathione measurement can depend on oxidation state and sample handling. A result described as total glutathione may answer a different question from one that distinguishes reduced and oxidized forms.

What the Glutathione Endotoxin Investigation Teaches
FDA investigated adverse events linked to glutathione material with potentially excessive endotoxin in compounded sterile preparations. The example illustrates why chemical purity and microbiological quality are different categories of evidence.

NAD+ Is a Cofactor, Not a Peptide
NAD+ is a cofactor rather than a peptide. Its inclusion in a peptide catalog is a merchandising choice, not a chemical classification, and sequence-based quality assumptions are not appropriate substitutes for its identity testing.

Topical Ingredient Literature Does Not Validate Every Format
A SNAP-8 listing should not inherit every claim made about a similarly named cosmetic ingredient. Sequence, formulation and model conditions are essential to deciding whether a paper addresses the supplied material.

Reading Melanotan II Adverse-Event Reports Responsibly
FDA cites serious case reports associated with Melanotan II in its compounding-risk resource. Such reports are safety signals that deserve explicit attention, not anecdotes to dismiss because a product is labeled for research.

Comparing Melanocortin Materials Without Assuming Equivalence
Melanotan-1, Melanotan-2 and PT-141 labels should be connected to their own structural records. Membership in a broad melanocortin discussion does not mean equal receptor activity, equivalent evidence or interchangeable material quality.

DSIP: A Historical Name Is Not Proof of a Sleep Mechanism
Delta sleep-inducing peptide is a historical name, not proof that every DSIP material has a demonstrated sleep effect. Naming, EEG observations and receptor hypotheses should be treated as distinct parts of an evidence review.

Evaluating a Neuroscience Blend Component by Component
A Selank and Semax mixture presents an analytical separation problem as well as a biological design problem. The presence of two ingredient names does not show that both are recoverable in the supplied proportions.

Why Analog Modifications Cannot Inherit Parent Evidence
An ADAMAX label requires a documented molecular definition before it is compared with Semax. A claimed modification does not automatically confer the parent material’s evidence or prove a stability advantage.